Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to aprende más. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RECURSOS

/

ENCUENTRA UN ESPECIALISTA

/

CONTACTO

kylie karley

Directora de Marketing y Comunicaciones

Kylie Karley serves as the Marketing & Communications Director at NephCure. Starting as the Content Marketing Manager in November 2018, she’s risen through the ranks and has grown with the organization to her current role. With a background in broadcast journalism, Kylie uses her passion for storytelling to bring stories to life across various platforms— even winning a Gold Anthem Award in 2022 for a digital awareness campaign she led for the organization. She is committed to uplifting and empowering everyone affected by rare kidney disease through her work, and genuinely enjoys meeting and connecting with NephCure families at different events across the country. Outside of the virtual office, you can find Kylie exploring her native city of Philadelphia, spending time with family and friends, going to the beach, and traveling to new places near and far!

Filadelfia, Pensilvania

Noticias relacionadas

NOTICIAS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NOTICIAS

NephCure Specialist of the Month: Dr. Rupali Avasare

NOTICIAS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NOTICIAS

NephCure Specialist of the Month: Dr. Fahad Aziz

Regístrese para recibir las últimas actualizaciones de NephCure.

INSCRIBIRSE
Este campo es para fines de validación y no debe modificarse.